Abbott Laboratories Operating Margin 2010-2025 | ABT

Current and historical operating margin for Abbott Laboratories (ABT) over the last 10 years. The current operating profit margin for Abbott Laboratories as of March 31, 2025 is 19.81%.
Abbott Laboratories Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $42.34B $7.13B 16.84%
2024-12-31 $41.95B $6.83B 16.27%
2024-09-30 $41.22B $6.69B 16.24%
2024-06-30 $40.73B $6.48B 15.92%
2024-03-31 $40.33B $6.36B 15.76%
2023-12-31 $40.11B $6.48B 16.15%
2023-09-30 $39.96B $6.00B 15.02%
2023-06-30 $40.23B $6.13B 15.23%
2023-03-31 $41.51B $6.96B 16.77%
2022-12-31 $43.65B $8.36B 19.16%
2022-09-30 $45.03B $9.44B 20.95%
2022-06-30 $45.55B $10.21B 22.42%
2022-03-31 $44.51B $9.23B 20.73%
2021-12-31 $43.08B $8.43B 19.56%
2021-09-30 $42.31B $8.48B 20.04%
2021-06-30 $40.23B $7.43B 18.46%
2021-03-31 $37.34B $6.71B 17.97%
2020-12-31 $34.61B $5.36B 15.48%
2020-09-30 $32.22B $4.31B 13.39%
2020-06-30 $31.44B $4.02B 12.78%
2020-03-31 $32.10B $4.55B 14.18%
2019-12-31 $31.90B $4.53B 14.21%
2019-09-30 $31.36B $4.31B 13.74%
2019-06-30 $30.94B $4.11B 13.27%
2019-03-31 $30.72B $3.78B 12.31%
2018-12-31 $30.58B $3.65B 11.94%
2018-09-30 $30.40B $3.14B 10.32%
2018-06-30 $29.58B $2.91B 9.84%
2018-03-31 $28.45B $2.41B 8.49%
2017-12-31 $27.39B $1.56B 5.71%
2017-09-30 $25.13B $1.70B 6.77%
2017-06-30 $23.61B $1.83B 7.75%
2017-03-31 $22.30B $2.26B 10.13%
2016-12-31 $20.85B $3.03B 14.51%
2016-09-30 $20.71B $3.05B 14.74%
2016-06-30 $20.56B $2.87B 13.95%
2016-03-31 $20.39B $2.78B 13.64%
2015-12-31 $20.41B $2.87B 14.05%
2015-09-30 $20.57B $2.88B 14.00%
2015-06-30 $20.50B $2.90B 14.13%
2015-03-31 $20.39B $2.84B 13.95%
2014-12-31 $20.25B $2.60B 12.84%
2014-09-30 $18.90B $2.19B 11.58%
2014-06-30 $18.65B $1.93B 10.37%
2014-03-31 $19.03B $1.88B 9.89%
2013-12-31 $19.66B $2.13B 10.85%
2013-09-30 $18.84B $1.69B 8.98%
2013-06-30 $19.28B $1.53B 7.93%
2013-03-31 $19.14B $1.47B 7.66%
2012-12-31 $19.05B $1.36B 7.14%
2012-09-30 $26.24B $3.47B 13.21%
2012-06-30 $30.79B $3.75B 12.18%
2012-03-31 $35.09B $4.96B 14.13%
2011-12-31 $38.85B $5.75B 14.80%
2011-09-30 $38.44B $5.50B 14.30%
2011-06-30 $37.30B $6.09B 16.31%
2011-03-31 $36.51B $5.92B 16.21%
2010-12-31 $35.17B $6.09B 17.31%
2010-09-30 $33.99B $6.12B 18.01%
2010-06-30 $33.08B $6.58B 19.89%
2010-03-31 $31.74B $6.65B 20.93%
2009-12-31 $30.76B $6.24B 20.27%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $232.442B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $153.655B 38.47
Stryker (SYK) United States $150.679B 31.51
EssilorLuxottica (ESLOY) France $135.238B 0.00
Medtronic (MDT) Ireland $114.659B 16.25
Lonza Group Ag (LZAGY) Switzerland $51.418B 0.00
Haleon (HLN) United Kingdom $45.416B 25.92
ResMed (RMD) United States $37.840B 28.42
Agilent Technologies (A) United States $35.272B 22.99
GE HealthCare Technologies (GEHC) United States $35.028B 16.63
Terumo (TRUMY) Japan $24.711B 32.10
Koninklijke Philips (PHG) Netherlands $23.746B 16.66
Insulet (PODD) United States $20.930B 82.15
Zimmer Biomet Holdings (ZBH) United States $18.825B 12.09
Baxter (BAX) United States $15.241B 11.38
Smith & Nephew SNATS (SNN) United Kingdom $13.608B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $7.072B 24.61
Lantheus Holdings (LNTH) United States $5.800B 14.63
Prestige Consumer Healthcare (PBH) United States $3.832B 17.12
Haemonetics (HAE) United States $3.755B 17.10
Perrigo (PRGO) Ireland $3.749B 9.50
Envista Holdings (NVST) United States $3.512B 29.18
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.378B 24.91
QuidelOrtho (QDEL) United States $2.134B 14.67
LeMaitre Vascular (LMAT) United States $1.937B 43.31
AtriCure (ATRC) United States $1.587B 0.00
Acuren (TIC) United States $1.427B 0.00
Green Thumb Industries (GTBIF) United States $1.357B 30.52
AdaptHealth (AHCO) United States $1.275B 12.94
Phibro Animal Health (PAHC) United States $1.262B 16.14
Neogen (NEOG) United States $1.211B 15.50
BioLife Solutions (BLFS) United States $1.087B 0.00
InMode (INMD) Israel $0.960B 9.67
Curaleaf Holdings (CURLF) Canada $0.818B 0.00
Kestra Medical Technologies (KMTS) United States $0.780B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.736B 0.00
Tilray Brands (TLRY) Canada $0.641B 0.00
Owens & Minor (OMI) United States $0.640B 5.31
Evolus (EOLS) United States $0.627B 0.00
CeriBell (CBLL) United States $0.606B 0.00
Capricor Therapeutics (CAPR) United States $0.521B 0.00
Valneva SE (VALN) France $0.511B 0.00
Surmodics (SRDX) United States $0.444B 0.00
SNDL (SNDL) Canada $0.373B 0.00
VAREX IMAGING (VREX) United States $0.352B 12.94
Cresco Labs (CRLBF) United States $0.342B 0.00
Sanuwave Health (SNWV) United States $0.307B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Cerus (CERS) United States $0.296B 0.00
Quanterix (QTRX) United States $0.292B 0.00
Viemed Healthcare (VMD) United States $0.276B 23.27
Sanara MedTech (SMTI) United States $0.273B 0.00
Aurora Cannabis (ACB) Canada $0.264B 78.17
ZimVie (ZIMV) United States $0.262B 11.90
Brainsway (BWAY) Israel $0.239B 63.17
Biote (BTMD) United States $0.230B 6.48
OraSure Technologies (OSUR) United States $0.228B 0.00
Verano Holdings (VRNOF) United States $0.225B 0.00
Canopy Growth (CGC) Canada $0.219B 0.00
Omeros (OMER) United States $0.203B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.194B 0.00
TriSalus Life Sciences (TLSI) United States $0.189B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.14
Vireo Growth (VREOF) United States $0.164B 0.00
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.124B 15.25
TerrAscend (TSNDF) Canada $0.115B 0.00
Fonar (FONR) United States $0.100B 12.91
MacroGenics (MGNX) United States $0.100B 0.00
Jushi Holdings (JUSHF) United States $0.098B 0.00
Jin Medical (ZJYL) China $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Veru (VERU) United States $0.085B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
Apyx Medical (APYX) United States $0.082B 0.00
InterCure (INCR) Israel $0.073B 0.00
Cytosorbents (CTSO) United States $0.071B 0.00
Agape ATP (ATPC) $0.071B 0.00
Zynex (ZYXI) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Rockwell Medical (RMTI) United States $0.044B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Nephros (NEPH) United States $0.040B 53.57
United-Guardian (UG) United States $0.038B 13.02
Safety Shot (SHOT) United States $0.032B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
INLIF (INLF) $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Senestech (SNES) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00